BeOne Medicines (HKSE:06160) Machinery, Furniture, Equipment : HK$796 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is BeOne Medicines Machinery, Furniture, Equipment?

BeOne Medicines's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2025 was HK$796 Mil.

BeOne Medicines's quarterly Machinery, Furniture, Equipment increased from Sep. 2024 (HK$653 Mil) to Dec. 2024 (HK$780 Mil) and increased from Dec. 2024 (HK$780 Mil) to Mar. 2025 (HK$796 Mil).

BeOne Medicines's annual Machinery, Furniture, Equipment increased from Dec. 2022 (HK$370 Mil) to Dec. 2023 (HK$650 Mil) and increased from Dec. 2023 (HK$650 Mil) to Dec. 2024 (HK$780 Mil).

BeOne Medicines Machinery, Furniture, Equipment Historical Data

The historical data trend for BeOne Medicines's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeOne Medicines Machinery, Furniture, Equipment Chart

BeOne Medicines Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

161.10

213.72

369.67

650.41

780.05

BeOne Medicines Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															522.00	528.34	653.00	780.05	795.70

BeOne Medicines Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

BeOne Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeOne Medicines Ltd (HKSE:06160) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

BEIGF:USA ONC:USA 49B:Germany 688235:China B1ME34:Brazil

Address

c/o BeOne Medicines I GmbH, Aeschengraben 27, 21st Floor, Basel, CHE, 4051

Website

https://www.beonemedicines.com

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

Executives

Baker Felix James	2201 Interest of corporation controlled by you
Baker Julian Charles	2201 Interest of corporation controlled by you
Baker Bros. Advisors (gp) Llc	2201 Interest of corporation controlled by you
Baker Brothers Life Sciences Capital, L.p.	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2502 Approved lending agent
Oyler John Victor	2101 Beneficial owner
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Hhlr Fund, L.p.	2101 Beneficial owner
Amgen Inc.	2101 Beneficial owner
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner
Fidelity Management & Research Company
Fmr Co., Inc.

BeOne Medicines Headlines

No Headlines